PubRank

Kazuhiro Mizumoto

Author PubWeight™ 114.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study. J Clin Oncol 2013 3.26
2 Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res 2004 2.42
3 MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther 2009 2.41
4 MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. Surgery 2011 2.06
5 alpha-Smooth Muscle Actin Expressing Stroma Promotes an Aggressive Tumor Biology in Pancreatic Ductal Adenocarcinoma. Pancreas 2010 1.94
6 MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation. Mol Cancer 2010 1.66
7 Transient phlebitis induced by a bolus injection of propofol. J Anesth 2006 1.41
8 Diagnostic significance of a dilated orifice of the duodenal papilla in intraductal papillary mucinous neoplasm of the pancreas. Gastrointest Endosc 2012 1.39
9 Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. Neoplasia 2010 1.36
10 Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clin Cancer Res 2002 1.36
11 The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Clin Cancer Res 2005 1.33
12 CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer. Gastroenterology 2010 1.33
13 Adult case of an omphalomesenteric cyst resected by laparoscopic-assisted surgery. World J Gastroenterol 2006 1.28
14 A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus. Cancer 2002 1.27
15 MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma. Ann Surg Oncol 2010 1.25
16 Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice. Int J Cancer 2007 1.19
17 MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. Cancer Biol Ther 2010 1.17
18 MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene. Ann Surg Oncol 2012 1.15
19 Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules. Pancreas 2010 1.14
20 Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol 2005 1.13
21 "High-risk stigmata" of the 2012 international consensus guidelines correlate with the malignant grade of branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2014 1.07
22 Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells. Cancer Res 2013 1.06
23 Down-regulation of deoxycytidine kinase enhances acquired resistance to gemcitabine in pancreatic cancer. Anticancer Res 2008 1.06
24 Enhanced cell migration and invasion of CD133+ pancreatic cancer cells cocultured with pancreatic stromal cells. Cancer 2010 1.05
25 Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells. Int J Cancer 2003 1.04
26 Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer. Clin Cancer Res 2005 1.03
27 An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas. Surgery 2011 1.02
28 Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer. Cancer Sci 2011 1.01
29 Tumor-stromal interactions with direct cell contacts enhance proliferation of human pancreatic carcinoma cells. Cancer Sci 2009 1.01
30 Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas. Hum Pathol 2010 1.00
31 S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis. Clin Cancer Res 2006 0.99
32 Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ann Surg 2013 0.98
33 Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas. Mol Cancer 2013 0.98
34 High EGFR mRNA expression is a prognostic factor for reduced survival in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. Int J Oncol 2011 0.97
35 Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type. Surgery 2010 0.96
36 MicroRNA expression analyses in preoperative pancreatic juice samples of pancreatic ductal adenocarcinoma. JOP 2010 0.96
37 LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer. Neoplasia 2009 0.96
38 Overexpression of c-met in the early stage of pancreatic carcinogenesis; altered expression is not sufficient for progression from chronic pancreatitis to pancreatic cancer. World J Gastroenterol 2006 0.95
39 Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers. World J Surg 2004 0.95
40 Repeated Pancreatectomy for Recurrent Pancreatic Carcinoma after Pylorus-Preserving Pancreatoduodenectomy: Report of Two Patients. Case Rep Gastroenterol 2010 0.94
41 Quantitative analysis of human telomerase reverse transcriptase in pancreatic cancer. Clin Cancer Res 2006 0.94
42 Quantitative analysis of MUC1 and MUC5AC mRNA in pancreatic juice for preoperative diagnosis of pancreatic cancer. Int J Cancer 2006 0.94
43 LIM only 4 is overexpressed in late stage pancreas cancer. Mol Cancer 2008 0.94
44 Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. Am J Surg 2011 0.93
45 S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples. Cancer Epidemiol Biomarkers Prev 2007 0.93
46 S100A4 mRNA is a diagnostic and prognostic marker in pancreatic carcinoma. J Gastrointest Surg 2009 0.93
47 MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer. Ann Surg Oncol 2011 0.93
48 Prospectively isolated cancer-associated CD10(+) fibroblasts have stronger interactions with CD133(+) colon cancer cells than with CD133(-) cancer cells. PLoS One 2010 0.92
49 S100P is an early developmental marker of pancreatic carcinogenesis. Clin Cancer Res 2006 0.92
50 S100P is a novel marker to identify intraductal papillary mucinous neoplasms. Hum Pathol 2010 0.91
51 Increased expression of ADAM 9 and ADAM 15 mRNA in pancreatic cancer. Anticancer Res 2007 0.90
52 Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade. Mod Pathol 2007 0.90
53 Predicting the chemosensitivity of pancreatic cancer cells by quantifying the expression levels of genes associated with the metabolism of gemcitabine and 5-fluorouracil. Int J Oncol 2011 0.90
54 Co-cultivation of pancreatic cancer cells with orthotopic tumor-derived fibroblasts: fibroblasts stimulate tumor cell invasion via HGF secretion whereas cancer cells exert a minor regulative effect on fibroblasts HGF production. Cancer Lett 2003 0.90
55 All-trans retinoic acid inhibits the cell proliferation but enhances the cell invasion through up-regulation of c-met in pancreatic cancer cells. Cancer Lett 2004 0.89
56 SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients. Anticancer Res 2010 0.89
57 Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review. Ann Surg 2014 0.88
58 Pancreatic cancer cells enhance the ability of collagen internalization during epithelial-mesenchymal transition. PLoS One 2012 0.88
59 Liver cyst with biliary communication successfully treated with laparoscopic deroofing: a case report. JSLS 2003 0.88
60 Vasodilation mediated by inward rectifier K+ channels in cerebral microvessels of hypertensive and normotensive rats. Anesth Analg 2006 0.87
61 Suppression of metastasis of human pancreatic cancer to the liver by transportal injection of recombinant adenoviral NK4 in nude mice. Int J Cancer 2005 0.87
62 Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma. Ann Surg Oncol 2011 0.87
63 Hypoxia enhances the interaction between pancreatic stellate cells and cancer cells via increased secretion of connective tissue growth factor. J Surg Res 2012 0.86
64 Invasive carcinoma derived from intestinal-type intraductal papillary mucinous neoplasm is associated with minimal invasion, colloid carcinoma, and less invasive behavior, leading to a better prognosis. Pancreas 2011 0.85
65 The role of the DNA damage checkpoint pathway in intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res 2007 0.85
66 Altered expression of MUTYH and an increase in 8-hydroxydeoxyguanosine are early events in ulcerative colitis-associated carcinogenesis. J Pathol 2009 0.84
67 Telomerase as a new target for pancreatic cancer treatment. J Hepatobiliary Pancreat Surg 2002 0.84
68 Role of ERCP in the era of EUS-FNA for preoperative cytological confirmation of resectable pancreatic ductal adenocarcinoma. Surg Today 2014 0.84
69 Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice. Cancer Gene Ther 2002 0.84
70 Laparoscopic choledochotomy for bile duct stones. J Hepatobiliary Pancreat Surg 2002 0.84
71 Combination with low-dose gemcitabine and hTERT-promoter-dependent conditionally replicative adenovirus enhances cytotoxicity through their crosstalk mechanisms in pancreatic cancer. Cancer Lett 2010 0.84
72 The mechanism behind the inhibitory effect of isoflurane on angiotensin II-induced vascular contraction is different from that of sevoflurane. Anesth Analg 2007 0.84
73 Micro RNA-373 is down-regulated in pancreatic cancer and inhibits cancer cell invasion. Ann Surg Oncol 2014 0.84
74 Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake. Clin Cancer Res 2008 0.83
75 Kindlin-2 expression in peritumoral stroma is associated with poor prognosis in pancreatic ductal adenocarcinoma. Pancreas 2013 0.82
76 Kindlin-1 expression is involved in migration and invasion of pancreatic cancer. Int J Oncol 2013 0.82
77 Half clamping of the infrahepatic inferior vena cava reduces bleeding during a hepatectomy by decreasing the central venous pressure. Langenbecks Arch Surg 2008 0.82
78 Unresectable pancreatic ductal adenocarcinoma in the remnant pancreas diagnosed during every-6-month surveillance after resection of branch duct intraductal papillary mucinous neoplasm: a case report. JOP 2013 0.82
79 Autoimmune pancreatitis diagnosed after pancreatoduodenectomy and successfully treated with low-dose steroid. J Hepatobiliary Pancreat Surg 2007 0.82
80 Adenoviral therapy is more effective in gemcitabine-resistant pancreatic cancer than in gemcitabine-sensitive cells. Anticancer Res 2011 0.81
81 REG4 is associated with carcinogenesis in the 'intestinal' pathway of intraductal papillary mucinous neoplasms. Mod Pathol 2009 0.81
82 Midkine mRNA is overexpressed in pancreatic cancer. Dig Dis Sci 2008 0.81
83 Quantitative analysis of hTERT mRNA levels in cells microdissected from cytological specimens. Cancer Sci 2008 0.81
84 Tumor-stroma interactions reduce the efficacy of adenoviral therapy through the HGF-MET pathway. Cancer Sci 2010 0.81
85 Involvement of Ca2+ sensitization in ropivacaine-induced contraction of rat aortic smooth muscle. Anesthesiology 2005 0.81
86 Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma. Pancreas 2015 0.81
87 Mass spectrometry-based metabolic profiling of gemcitabine-sensitive and gemcitabine-resistant pancreatic cancer cells. Pancreas 2014 0.81
88 Strategy for prevention of local recurrence of pancreatic cancer after pancreatectomy: antitumor effect of gemcitabine mixed with fibrin glue in an orthotopic nude mouse model. Surgery 2006 0.81
89 Effectiveness of bolus landiolol on paroxysmal atrial tachycardia. Can J Anaesth 2005 0.80
90 Elevated expression level of microRNA-196a is predictive of intestinal-type intraductal papillary mucinous neoplasm of the pancreas. Pancreas 2014 0.80
91 S100A4 mRNA expression level is a predictor of radioresistance of pancreatic cancer cells. Oncol Rep 2013 0.80
92 Spleen-preserving laparoscopic distal pancreatectomy after division of the splenic vessels. J Laparoendosc Adv Surg Tech A 2004 0.80
93 Factors in intraductal papillary mucinous neoplasms of the pancreas predictive of lymph node metastasis. Pancreatology 2011 0.80
94 MAL2 expression predicts distant metastasis and short survival in pancreatic cancer. Surgery 2013 0.80
95 ERT following IORT improves survival of patients with resectable pancreatic cancer. Hepatogastroenterology 2005 0.80
96 A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients. Cancer 2004 0.80
97 Predictive Factors for the Metachronous Development of High-risk Lesions in the Remnant Pancreas After Partial Pancreatectomy for Intraductal Papillary Mucinous Neoplasm. Ann Surg 2016 0.80
98 Migratory activity of CD105+ pancreatic cancer cells is strongly enhanced by pancreatic stellate cells. Pancreas 2013 0.79
99 Tissue tablet method: an efficient tissue banking procedure applicable to both molecular analysis and frozen tissue microarray. Hum Pathol 2014 0.79
100 [Phase I/II study of combination chemotherapy with gemcitabine and UFT for advanced pancreatic cancer in a multi-center trial]. Gan To Kagaku Ryoho 2008 0.79
101 CD271⁺ subpopulation of pancreatic stellate cells correlates with prognosis of pancreatic cancer and is regulated by interaction with cancer cells. PLoS One 2012 0.79
102 New infusion device for trans-tissue, sustained local delivery of anticancer agent to surgically resected tissue: potential use for suppression of local recurrence of pancreatic cancer. J Biomed Mater Res B Appl Biomater 2005 0.78
103 Chemotherapeutic agents potentiate adenoviral gene therapy for pancreatic cancer. Cancer Sci 2009 0.78
104 Role of endoscopic retrograde pancreatography for early detection of pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm of the pancreas. J Hepatobiliary Pancreat Sci 2013 0.78
105 Cell-based protein delivery system for the inhibition of the growth of pancreatic cancer: NK4 gene-transduced oral mucosal epithelial cell sheet. Clin Cancer Res 2003 0.78
106 Role of pancreatic juice cytology in the preoperative management of intraductal papillary mucinous neoplasm of the pancreas in the era of international consensus guidelines 2012. World J Surg 2014 0.78
107 hTERT-promoter-dependent oncolytic adenovirus enhances the transduction and therapeutic efficacy of replication-defective adenovirus vectors in pancreatic cancer cells. Cancer Sci 2009 0.78
108 Expression of claudin-4 (CLDN4) mRNA in intraductal papillary mucinous neoplasms of the pancreas. Mod Pathol 2010 0.77
109 Novel strategic therapeutic approaches for prevention of local recurrence of pancreatic cancer after resection: trans-tissue, sustained local drug-delivery systems. J Control Release 2004 0.77
110 Frozen section and permanent diagnoses of the bile duct margin in gallbladder and bile duct cancer. HPB (Oxford) 2005 0.77
111 Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4. Clin Cancer Res 2002 0.77
112 [Surgical treatment of gastroentero-pancreatic neuroendocrine tumor]. Gan To Kagaku Ryoho 2013 0.77
113 The inhibitory effects of isoflurane on protein tyrosine phosphorylation-modulated contraction of rat aortic smooth muscle. Anesthesiology 2004 0.77
114 Inhibition of p600 expression suppresses both invasiveness and anoikis resistance of gastric cancer. Ann Surg Oncol 2011 0.77
115 CD44v6 expression in intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2010 0.77
116 The inhibitory effects of sevoflurane on angiotensin II- induced, p44/42 mitogen-activated protein kinase-mediated contraction of rat aortic smooth muscle. Anesth Analg 2005 0.77
117 Up-regulation of integrin beta3 in radioresistant pancreatic cancer impairs adenovirus-mediated gene therapy. Cancer Sci 2009 0.76
118 Podoplanin expression in the cyst wall correlates with the progression of intraductal papillary mucinous neoplasm. Virchows Arch 2014 0.76
119 Insig2 is overexpressed in pancreatic cancer and its expression is induced by hypoxia. Cancer Sci 2011 0.76
120 Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers. Pancreas 2016 0.76
121 A minimally invasive and simple screening test for detection of pancreatic ductal adenocarcinoma using biomarkers in duodenal juice. Pancreas 2013 0.76
122 Gene transduction of NK4, HGF antagonist, inhibits in vitro invasion and in vivo growth of human pancreatic cancer. Clin Exp Metastasis 2002 0.75
123 Expression of glucagon-like Peptide 1 receptor and its effects on biologic behavior in pancreatic neuroendocrine tumors. Pancreas 2014 0.75
124 Halothane does not protect against vascular injury in isolated cerebral and mesenteric arteries. Can J Anaesth 2005 0.75
125 [Multi-center trial of gemcitabine for 49 patients with advanced pancreatic cancer]. Gan To Kagaku Ryoho 2003 0.75
126 Familial pancreatic cancer: report of one Japanese family. J Hepatobiliary Pancreat Surg 2004 0.75
127 Effects of isoflurane and sevoflurane anesthesia on arteriovenous shunt flow in the lower limb of diabetic patients without autonomic neuropathy. Anesthesiology 2007 0.75
128 Augmented activity of adenosine triphosphate-sensitive K+ channels induced by droperidol in the rat aorta. Anesth Analg 2006 0.75
129 Clinicopathological Characteristics of Young Patients With Pancreatic Cancer: An Analysis of Data From Pancreatic Cancer Registry of Japan Pancreas Society. Pancreas 2016 0.75
130 Atrial natriuretic peptide infusion for a neonate undergoing repair of congenital diaphragmatic hernia. J Anesth 2002 0.75
131 Combination therapy of portal vein resection and adjuvant gemcitabine improved prognosis of advanced pancreatic cancer. Hepatogastroenterology 2013 0.75
132 Reduction of adhesion formation by an angiotensin type 1 receptor antagonist. Langenbecks Arch Surg 2010 0.75
133 Sevoflurane enhances nitroglycerin tolerance in rat aorta: implications for the desensitization of soluble guanylate cyclase possibly through the additive generation of superoxide anions and/or hydroxyl radicals within vascular smooth muscle. Anesth Analg 2005 0.75
134 Radiation therapy, bypass operation and celiac plexus block in patients with unresectable locally advanced pancreatic cancer. Hepatogastroenterology 2005 0.75
135 A history of acute pancreatitis in intraductal papillary mucinous neoplasms of the pancreas is a potential predictive factor for malignant papillary subtype. Pancreatology 2011 0.75
136 Senescence in intraductal papillary mucinous neoplasm of the pancreas. Hum Pathol 2011 0.75
137 Predictors and Diagnostic Strategies for Early-Stage Pancreatic Ductal Adenocarcinoma: A Retrospective Study. Pancreas 2015 0.75
138 Presacral dermoid cyst with scanty fat component: usefulness of chemical shift and diffusion-weighted MR imaging. Comput Med Imaging Graph 2003 0.75
139 Laparoscopic surgery is applicable for larger mucinous cystic neoplasms of the pancreas. J Hepatobiliary Pancreat Sci 2013 0.75
140 [Pancreatic tumor: progress in diagnosis and treatment topics: I. Pancreatic carcinoma; 1. Epidemiology, risk factor, symptom]. Nihon Naika Gakkai Zasshi 2012 0.75
141 [Molecular biology-based diagnosis and therapy for pancreatic cancer]. Fukuoka Igaku Zasshi 2011 0.75
142 [Survival benefits of chemotherapy for unresectable biliary tract cancer--a multicenter retrospective analysis]. Gan To Kagaku Ryoho 2010 0.75